Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts

Journal of Rheumatology

Volumn 29, Issue 2, 2002, Pages 230-239

  Scott, Boyd B ^a   Zaratin, Paola F ^a   Colombo, Antonio ^a   Hansbury, Michael J ^a   Winkler, James D ^a   Jackson, Jeffrey R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Ang 1; Ang 2; Angiogenesis; Angiopoietin; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOPHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOMODULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; RNA, MESSENGER; SYNOVIAL MEMBRANE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036160784     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Angiogenesis
2. Blood vessel formation: What is its molecular basis?
3. The role of angiogenesis in tumor growth
4. Angiogenesis in cancer, vascular, rheumatoid and other disease
5. T cell-independant cellular pathways of rheumatoid joint destruction
6. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors
7. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors
8. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
9. Molecular cloning and characterization of mouse tie and tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells
10. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
11. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains
12. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
13. Tie2, a putative protein tyrosine kinase from a new class of cell surface receptor
14. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
15. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage
16. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta
17. Expression of tie receptor tyrosine kinase in leukemia cell lines
18. Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas
19. The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis
20. Distinct roles of the receptor tyrosine kinases tie-1 and tie-2 in blood vessel formation
21. Regulation of angiopoietin-2 mRNA levels in bovine microvasculature endothelial cells by cytokines and hypoxia
22. Isolation of angiopoietin-1 a ligand for the TIE2 receptor by secretion-trap expression cloning
23. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis
24. Requisite role of angiopoietin-1 a ligand for the TIE2 receptor, during embryonic angiogenesis
25. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
26. Signalling vascular morphogenesis and maintenance
27. Vascular endothelial growth factor and the angiopoietins working together to build a better blood vessel
28. Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implications
29. Hypoxia and inflammatory synovitis: Observations and speculation
30. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
31. Aberrant production of gliostatin/platelet derived cell growth factor in rheumatoid synovium
32. Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluids
33. Detection of tumour necrosis factor in rheumatoid arthritis synovial fluid and serum
34. Transforming growth factor beta production from synovial tissue from rheumatoid patients and streptococcal cell wall arthritic rats: Studies on secretion by synovial fibroblast-like cells and immunohistological localization
35. Cachectin/tumour necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts
36. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
37. Do nonimmunological mediated pathways play a role in the pathogenesis of rheumatoid arthritis
38. How important are T cells in chronic rheumatoid synovitis
39. Molecular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction
40. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β
41. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
42. 2
43. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells
44. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
45. Angiogenesis in pannus formation
46. Cell type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
47. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2
48. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia